Background on C9orf72 Expansions and iNPH

The C9orf72 gene, located on chromosome 9, is known for hexanucleotide repeat expansions that play a significant role in neurodegenerative diseases. Full expansions, typically exceeding 30 repeats, are strongly linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Intermediate expansions, ranging from approximately 10 to 30 repeats, have been observed in various conditions but their pathological significance remains under investigation.

Idiopathic normal pressure hydrocephalus (iNPH) is a neurological disorder characterized by enlarged brain ventricles, gait disturbance, cognitive impairment, and urinary incontinence, often treatable through cerebrospinal fluid diversion. Recent studies have explored connections between iNPH and genetic factors, including C9orf72 expansions.

A team of researchers from institutions including the University of Eastern Finland and Kuopio University Hospital examined fibroblasts derived from iNPH patients carrying these intermediate expansions. Their work highlights subtle cellular changes without the hallmark pathologies seen in ALS or FTD.

The Research Team and Publication Details

The study was led by authors Dorit Hoffmann, Ville Korhonen, Hannah Rostalski, Nadine Huber, Sami Heikkinen, Tomi Hietanen, Rebekka Wittrahm, Stina Leskelä, Päivi Hartikainen, Tuomas Rauramaa, Eino Solje, Anne M. Portaankorva, Mikko Hiltunen, Ville Leinonen, and Annakaisa Haapasalo. It appears in the journal Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Readers can access the full paper at the original publication.

This collaborative effort draws on expertise in molecular sciences, neurosurgery, neurology, pathology, and clinical medicine, reflecting the interdisciplinary nature of modern neurodegenerative research.

Study Methods and Approach

Researchers collected skin fibroblasts from iNPH patients identified with intermediate C9orf72 hexanucleotide repeat expansions through genetic screening. These cells were compared to those from iNPH patients without such expansions and healthy controls.

Key analyses included assessment of repeat length, RNA foci formation, dipeptide repeat protein production, and markers of cellular stress. Energy metabolism was evaluated through mitochondrial function assays, ATP production measurements, and Seahorse extracellular flux analysis to quantify oxygen consumption and extracellular acidification rates.

Additional tests examined autophagy, proteostasis, and inflammatory responses to determine if intermediate expansions triggered any of the cellular pathologies typical of full expansions.

Key Findings on Energy Metabolism

The fibroblasts carrying intermediate expansions exhibited clear alterations in energy metabolism. Mitochondrial respiration was impaired, with reduced basal and maximal oxygen consumption rates. ATP levels were lower compared to controls, suggesting inefficient energy production.

These changes occurred without the formation of RNA foci or production of toxic dipeptide repeat proteins, which are hallmarks of full C9orf72 expansions in ALS and FTD models. No evidence of nucleocytoplasmic transport defects or significant TDP-43 pathology was detected.

The metabolic shifts point to a potential vulnerability in cellular energy homeostasis that could contribute to broader neurological symptoms in iNPH, even in the absence of overt cell death or aggregation pathologies.

Absence of Typical Cell Pathologies

Despite the metabolic changes, the cells showed no signs of the protein aggregation or RNA toxicity associated with pathogenic C9orf72 expansions. This distinction is important because it suggests intermediate repeats may exert effects through different mechanisms, possibly related to subtle gene expression changes or mitochondrial dysfunction rather than toxic gain-of-function.

The findings help refine understanding of the repeat length threshold required for full pathological cascades. Intermediate expansions appear to represent a gray zone where metabolic stress emerges but full neurodegeneration does not necessarily follow in peripheral cells like fibroblasts.

Implications for Neurodegenerative Disease Research

This work contributes to the growing body of evidence that C9orf72 expansions exist on a spectrum. Understanding intermediate repeats could inform risk stratification in patients presenting with overlapping symptoms of iNPH and neurodegenerative conditions.

Clinicians and researchers may benefit from incorporating metabolic profiling into diagnostic panels for iNPH patients, particularly those with genetic predispositions. Early identification of energy metabolism deficits could guide supportive therapies aimed at mitochondrial health.

The study also underscores the value of patient-derived fibroblasts as accessible models for investigating disease mechanisms without relying solely on postmortem brain tissue or animal models.

Broader Context in Academic and Clinical Neuroscience

Research into C9orf72 and related genes continues to drive advancements in precision medicine. Institutions worldwide are expanding programs in neurogenetics and cellular bioenergetics to address the rising prevalence of age-related neurological disorders.

Findings like these encourage cross-disciplinary collaboration between basic scientists and clinicians, fostering environments where discoveries translate more rapidly into patient care. Universities are increasingly seeking faculty with expertise in mitochondrial biology, repeat expansion disorders, and hydrocephalus research.

Future Directions and Outlook

Future studies could explore whether the observed metabolic changes in fibroblasts correlate with central nervous system dysfunction in iNPH. Longitudinal tracking of patients with intermediate expansions may reveal progression patterns or protective factors.

Therapeutic strategies targeting mitochondrial function or energy metabolism represent promising avenues. Compounds that enhance cellular respiration or reduce oxidative stress warrant investigation in relevant models.

As genetic screening becomes more routine in neurology clinics, data on intermediate expansions will help refine counseling and monitoring protocols for at-risk individuals.

Relevance to Academic Careers in Research

Publications of this caliber highlight opportunities for early-career researchers in molecular neuroscience and clinical genetics. Postdoctoral positions and faculty roles focused on cellular models of neurodegeneration are in demand at leading institutions.

Professionals interested in advancing similar work can explore specialized opportunities in higher education and research sectors through dedicated academic job platforms.

Photo by Rubaitul Azad on Unsplash